SION (SION) reported R&D of $18.96M in Q1 2026.

How has SION's R&D changed year-over-year?

SION's R&D increased by 38.7% year-over-year, from $13.67M to $18.96M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

SION SION R&D

R&D at other companies

Septerna, Inc.SEPN

$29.54M+53.3%

BioCryst PharmaceuticalsBCRX

$60.32M+61.8%

Denali Therapeutics Inc.DNLI

$103.85M-10.7%

Neurocrine BiosciencesNBIX

$296.2M+12.5%

Other financials

Income statement

See full

Operating income-$29.6M-50.6%

Net income-$26.8M-62.5%

EPS (diluted)-$0.60+3.2%

Balance sheet

See full

Cash & equivalents$64.3M-23.2%

Total debt$8.4M-11.8%

Total equity$288.2M-18.1%

Total assets$305.0M-17.5%

Cash flow

See full

Operating cash flow-$21.8M-34.1%

CapEx--100%

Free cash flow-$21.8M-33.4%

Valuation

See full

Market cap$1.86B—

Returns & leverage

See full

Return on equity-26.7%—

Debt / equity0×0.0×

Current ratio22.6×-6.1×

Where this comes from

Reported directly by SION in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: SION’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SION's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is SION's R&D?: SION (SION) reported R&D of $18.96M in Q1 2026.
How has SION's R&D changed year-over-year?: SION's R&D increased by 38.7% year-over-year, from $13.67M to $18.96M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.